• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药的使用:超越抑郁和焦虑的拓展。

Use of antidepressants: expansion beyond depression and anxiety.

作者信息

Cascade Elisa F, Kalali Amir H, Thase Michael E

机构信息

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia.

出版信息

Psychiatry (Edgmont). 2007 Dec;4(12):25-8.

PMID:20436760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2861511/
Abstract

We investigated antidepressant prescriptions and reasons for use. According to our data, the top 10 molecules represent approximately 95% of total antidepressant prescriptions for both primary care physicians (PCPs) and psychiatrists. The primary difference between PCPs and psychiatrists was the increased use of buproprion and tricyclics/tetracyclics by psychiatrists. The selective serotonin reuptake inhibitors (SSRIs) and other newer antidepressants such as venlafaxine (Effexor) and buproprion (Wellbutrin) are used to treat depression, anxiety, and bipolar disorders. The noted exception is duloxetine (Cymbalta), which looks like a blend between the newer agents and the tricyclics where there is use beyond the traditional central nervous system (CNS) disorders into pain and migraine.

摘要

我们调查了抗抑郁药的处方情况及用药原因。根据我们的数据,对于初级保健医生(PCP)和精神科医生而言,排名前十的药物分子约占抗抑郁药总处方量的95%。PCP和精神科医生之间的主要差异在于,精神科医生增加了安非他酮以及三环类/四环类药物的使用。选择性5-羟色胺再摄取抑制剂(SSRI)以及其他新型抗抑郁药,如文拉法辛(怡诺思)和安非他酮(安非他酮),用于治疗抑郁症、焦虑症和双相情感障碍。值得注意的例外是度洛西汀(欣百达),它似乎是新型药物和三环类药物的混合体,其应用范围超越了传统的中枢神经系统(CNS)疾病,还用于疼痛和偏头痛。

相似文献

1
Use of antidepressants: expansion beyond depression and anxiety.抗抑郁药的使用:超越抑郁和焦虑的拓展。
Psychiatry (Edgmont). 2007 Dec;4(12):25-8.
2
IPS multicentric study: Antidepressant prescription patterns.IPS 多中心研究:抗抑郁药处方模式。
Indian J Psychiatry. 2013 Jan;55(1):41-5. doi: 10.4103/0019-5545.105503.
3
Serotonin and Norepinephrine Reuptake Inhibitors.5-羟色胺及去甲肾上腺素再摄取抑制剂
Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164.
4
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.
5
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.药物依从性和医疗资源利用模式的差异:老年与新型抗抑郁药在抑郁症和/或焦虑症患者中的应用
CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005.
6
Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.英国药品安全委员会的建议对英国儿童和青少年抗抑郁药处方的影响。
Drug Saf. 2005;28(12):1151-7. doi: 10.2165/00002018-200528120-00009.
7
Are antidepressants all the same? Surveying the opinions of Australian psychiatrists.抗抑郁药都一样吗?对澳大利亚精神科医生观点的调查。
Aust N Z J Psychiatry. 1999 Oct;33(5):642-9. doi: 10.1080/j.1440-1614.1999.00632.x.
8
Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care.成人初级保健中选择性5-羟色胺再摄取抑制剂及其他新型抗抑郁药的处方趋势
Prim Care Companion J Clin Psychiatry. 2003 Aug;5(4):153-157. doi: 10.4088/pcc.v05n0402.
9
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement.意大利初级保健中抗抑郁药的处方:选择性5-羟色胺再摄取抑制剂纳入报销范围后的使用模式
Eur J Clin Pharmacol. 2004 Jan;59(11):825-31. doi: 10.1007/s00228-003-0692-1. Epub 2003 Nov 11.
10
A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose.对度洛西汀和文拉法辛在初级保健中用于治疗抑郁症患者的适宜性进行综述,重点关注心血管安全性、因抗抑郁药过量导致的自杀和死亡率。
Ther Adv Psychopharmacol. 2013 Jun;3(3):151-61. doi: 10.1177/2045125312472890.

引用本文的文献

1
Impact of antidiabetic medication type on a new episode of depression: a retrospective cohort study in Texas, USA.抗糖尿病药物类型对新发抑郁症的影响:美国德克萨斯州的一项回顾性队列研究
BMJ Open. 2025 Apr 23;15(4):e087694. doi: 10.1136/bmjopen-2024-087694.
2
Drug Permeability: From the Blood-Brain Barrier to the Peripheral Nerve Barriers.药物渗透性:从血脑屏障到外周神经屏障
Adv Ther (Weinh). 2023 Apr;6(4). doi: 10.1002/adtp.202200150. Epub 2023 Jan 18.
3
Examining clinician choice to follow-up (or not) on automated notifications of medication non-adherence by clinical decision support systems.考察临床医生是否根据临床决策支持系统自动发出的药物不依从通知进行随访(或不进行随访)的选择。
BMC Med Inform Decis Mak. 2023 Jan 30;23(1):22. doi: 10.1186/s12911-022-02091-2.
4
Use of hormonal contraceptives and antidepressants and risks of suicidal behavior and accidents among women with premenstrual disorders: a nationwide cohort study.使用激素避孕药和抗抑郁药与经前期障碍妇女自杀行为和事故风险的关系:一项全国性队列研究。
BMC Med. 2022 Dec 15;20(1):482. doi: 10.1186/s12916-022-02671-z.
5
Antidepressant Prescription for Major Depressive Disorder: Results from a Population-Based Study in Italy.抗抑郁药治疗重度抑郁症:意大利一项基于人群的研究结果。
Curr Neuropharmacol. 2022 Nov 15;20(12):2381-2392. doi: 10.2174/1570159X20666220222142310.
6
Neuroenhancement: State of the Art and Future Perspectives.神经增强:现状与未来展望。
Clin Neuropsychiatry. 2021 Jun;18(3):137-169. doi: 10.36131/cnfioritieditore20210303.
7
Impact of duloxetine on male fertility: A randomised controlled clinical trial.度洛西汀对男性生育力的影响:一项随机对照临床试验。
Andrologia. 2021 Nov;53(10):e14207. doi: 10.1111/and.14207. Epub 2021 Aug 9.
8
First indication of deleterious impacts in white-seabream larvae (Diplodus sargus) survival and behaviour following acute venlafaxine exposure.急性文拉法辛暴露后,白鲷幼鱼(Diplodus sargus)生存和行为出现有害影响的初步迹象。
Ecotoxicology. 2019 Aug;28(6):612-618. doi: 10.1007/s10646-019-02057-7. Epub 2019 Jun 1.
9
Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors.前列腺癌幸存者自我报告的抑郁临床诊断和治疗的模式和预测因素。
Cancer Med. 2019 Jul;8(8):3648-3658. doi: 10.1002/cam4.2239. Epub 2019 May 20.
10
Pharmacokinetic interactions study between carvedilol and some antidepressants in rat liver microsomes - a comparative study.卡维地洛与某些抗抑郁药在大鼠肝微粒体中的药代动力学相互作用研究——一项比较研究。
Med Pharm Rep. 2019 Apr;92(2):158-164. doi: 10.15386/mpr-1225. Epub 2019 Apr 25.

本文引用的文献

1
Treatment of depression: antidepressant monotherapy and combination therapy.抑郁症的治疗:抗抑郁药单一疗法与联合疗法。
Psychiatry (Edgmont). 2007 Nov;4(11):25-7.
2
Effectiveness of adjunctive antidepressant treatment for bipolar depression.辅助抗抑郁药治疗双相抑郁症的疗效
N Engl J Med. 2007 Apr 26;356(17):1711-22. doi: 10.1056/NEJMoa064135. Epub 2007 Mar 28.
3
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.双相抑郁中的情绪转换:文拉法辛、安非他酮和舍曲林辅助治疗的比较
Br J Psychiatry. 2006 Aug;189:124-31. doi: 10.1192/bjp.bp.105.013045.
4
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.米氮平与去甲替林对门诊抑郁症患者连续两次药物治疗失败后的疗效比较:一项STAR*D报告
Am J Psychiatry. 2006 Jul;163(7):1161-72. doi: 10.1176/ajp.2006.163.7.1161.
5
Medication augmentation after the failure of SSRIs for depression.5-羟色胺再摄取抑制剂治疗抑郁症失败后的药物增效治疗。
N Engl J Med. 2006 Mar 23;354(12):1243-52. doi: 10.1056/NEJMoa052964.
6
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.安非他酮或选择性5-羟色胺再摄取抑制剂抗抑郁治疗后的缓解率:来自7项随机对照试验原始数据的荟萃分析
J Clin Psychiatry. 2005 Aug;66(8):974-81. doi: 10.4088/jcp.v66n0803.
7
A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.一项关于辅助使用安非他酮缓释剂治疗选择性5-羟色胺再摄取抑制剂(SSRI)所致性功能障碍的安慰剂对照、随机、双盲研究。
J Clin Psychiatry. 2005 Jul;66(7):844-8. doi: 10.4088/jcp.v66n0706.
8
Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.2000年双相情感障碍的药物治疗:专家共识指南摘要
J Psychiatr Pract. 2000 Jul;6(4):197-211. doi: 10.1097/00131746-200007000-00004.
9
Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.难治性抑郁症的治疗选择:证据现状的叙述性综述
CNS Spectr. 2004 Nov;9(11):808-16, 818-21. doi: 10.1017/s1092852900002236.